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Syndecan are a family of cell surface heparan sulfate proteoglycans that act as cell surface receptors.
Most cell surface receptors have a limited number and type of ligand interactions, responding only
to the binding of (a) speciﬁc ligand(s). In contrast, syndecans can interact with various numbers and
types of ligands, and thus play more diverse roles than others. Various syndecan functions have not
yet been fully classiﬁed and categorized, but we herein review previous studies suggesting that syn-
decans play dual function as cell surface receptors by acting as both adhesion receptors and docking
receptors. Through this dual regulatory function, syndecans are capable of regulating both intra-
and extracellular activities, potentially altering a variety of cell behaviors.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Syndecan cell surface heparan sulfate proteoglycans are a
family of type I transmembrane proteins [1] whose extracellular
domains interact with various soluble and insoluble factors in
the extracellular matrix (ECM) [2]. These interactions activate
syndecans, allowing them to regulate various signaling events both
inside and outside the cell [3]. Syndecans are typical cell surface
receptors, in that they typically respond to the binding of extracel-
lular ligands. Unlike other receptors, such as those for growth fac-
tors and cytokines, however, syndecans have additional, unique
characteristics. Through glycosaminoglycan chains attached to
the core protein, syndecans can interact with a various numberal Societies. Published by Elsevier
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per syndecan molecule is much higher than that of growth factor
receptors. Syndecans can also interact with many different types
of soluble and insoluble proteins, lipids, and even microorganisms
[1]. These characteristics together with other structural features
allow syndecans to fulﬁll more diverse functions than other recep-
tors. However, if we look carefully at syndecan-mediated regula-
tory signaling, there appear to be some common regulatory
mechanisms. Here, we discuss two ways in which syndecans act
as cell surface receptors: as adhesion receptors, and as docking
receptors. In the context of an adhesion receptor, the interaction
of the extracellular domain of a syndecan with a ligand triggers
the transduction of signals from the extracellular environment to
the cytosol, leading to changes in the intracellular environment.
As a docking receptor, in contrast, a syndecan can mediate several
extracellular events. Through these dual regulatory mechanisms,
syndecans are capable of regulating both intracellular and extra-
cellular events, in turn leading to changes in a variety of cell behav-
iors (Fig. 1).
2. Syndecan as a cell adhesion receptor
The adhesion of cells to the ECM provides physical support,
regulates cell positioning and transduces signals to initiate proper
responses [4]; this adhesion occurs via cell adhesion receptors,B.V. Open access under CC BY-NC-ND license. 
Fig. 1. The dual regulatory mechanisms of syndecans. Syndecans play dual roles as cell surface receptors. (A) In the context of an adhesion receptor, the extracellular domain
of a syndecan transduces signals from the extracellular environment to the cytosol, thereby regulating intracellular signaling events such as cytoskeletal organization,
morphological changes in migrating cells and proliferation. (B) As a docking receptor, a syndecan can regulate extracellular events. When extracellular ligands bind to
syndecan, (i) extracellular enzymes such as MMPs become activated, (ii) soluble ligands are diluted much less and can achieve high local concentrations, and (iii) extracellular
ligands such as growth factors bind with high afﬁnities to their receptors. Through these dual regulatory mechanisms, syndecans can regulate events both inside and outside
the cell. E, extracellular domain; T, transmembrane domain; and C, cytoplasmic domain.
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integrin with the ECM is tightly linked to the phosphorylation
states and activities of cytosolic tyrosine kinases, such as focal
adhesion kinase and Src family kinases, which subsequently regu-
late other kinases, scaffolding proteins and intracellular signaltransduction. This is the typical example of adhesion receptor-
mediated signal transduction, such as that by integrin family mem-
bers. Integrins and syndecans both regulate many cellular events,
such as gene expression, proliferation, differentiation, cell mor-
phology and motility [1,5].
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adhesion formation on ﬁbronectin-coated cells [6]. Although the
extracellular domain of integrin is sufﬁcient for the attachment
and spreading of primary ﬁbroblasts, it is not sufﬁcient to direct fo-
cal adhesion and stress ﬁber formation. Instead, the formation and
maturation of adhesion complexes requires the glycosaminoglycan
(GAG) chains of syndecan-4 and/or the core syndecan-4 protein,
which bind the heparin-binding domain II of ﬁbronectin [6,7], trig-
gering the activation of protein kinase Ca (PKCa) [6,8] and the sub-
sequent modulation of the Rho GTPases [9]. In this case, the
interaction of syndecan-4 with an extracellular ligand, ﬁbronectin,
induces and stabilizes the oligomerization of the syndecan-4 trans-
membrane domain, transduces an extracellular signal to the cyto-
sol, and ultimately regulates intracellular events, such as
cytoskeletal rearrangement and the formation of focal adhesions.
Recent studies on ﬁbronectin-coated cells have revealed that synd-
ecan-4 cooperates with integrin a5b1 to activate Rac, a major regu-
lator of cell migration [9,10], and induce directional cell migration
[11]. Two other interacting proteins, paxillin [12] and Tiam-1might
be also associated with the syndecan-4-containing protein complex
and could support the activation of Rac1 [13]. Interaction of syndec-
an-4 with laminin 332, particularly via the C-terminal globular do-
main of the former protein, is involved in regulation of keratinocyte
migration during epidermal repair [14]. As an adhesion receptor,
syndecan-4 is also likely to be involved in the generation of reactive
oxygen species (ROS) [15] during cell spreading and adhesion, prob-
ably through the activation of Rac1 [16].
Similarly, studies have shown that syndecan-2 and integrins ap-
pear to cooperate in the formation of stress ﬁbers. Knockdown of
syndecan-2 with an antisense oligonucleotide inhibited the forma-
tion of actin stress ﬁbers, and syndecan-2 was shown to interact
with ﬁbronectin and cooperate with integrin a5b1 to regulate actin
stress ﬁber formation in Lewis lung carcinoma-derived P29 cells
[17]. In P29 cells, syndecan-2 cooperated with a5b1 integrin to
form actin stress ﬁbers on a ﬁbronectin substratum, whereas cells
expressing syndecan-2 alone formed ﬁlopodia [18]. Cooperation
between syndecan-2 and a2b1 integrin has also been reported dur-
ing cell adhesion and migration in normal epithelial cells and colon
cancer cells [19]. Similar to the interaction of PKCawith syndecan-
4, protein kinase A (PKA) activity is related to syndecan-2-medi-
ated intracellular signaling in HEK cells and cultured hippocampal
neurons, where it triggers the formation of ﬁlopodia and dendritic
spines [20]. Syndecan-2 is known to be essential for angiogenesis
[21] and can regulate the tumorigenic activity of HT1080 ﬁbrosar-
coma cells [14], but future work will be required to assess the
mechanisms through which extracellular ligands regulate syndec-
an-2 in these cases.
Various studies have shown that syndecan-1 regulates avb3
integrin [22], modulates avb5 integrin during cell adhesion to
vitronectin [23], and promotes cell adhesion to laminin-332 by
inhibiting the phosphorylation of b4 integrin [24]. In addition,
syndecan-1 acts as a critical regulator of the avb3 and avb5 inte-
grins during angiogenesis and tumorigenesis [25]. Cooperative reg-
ulation between syndecan-1 and a2b1 integrin has been suggested
during cell adhesion to collagen [26], which negatively modulates
cancer cell movement [27]. The interaction between syndecan-1
and collagen I was shown to control the Rho GTPases, activating
and suppressing the activities of RhoA and Rac1, respectively
[28]. The activation of RhoA by the binding of syndecan-1 to colla-
gen I was found to induce focal adhesions and reduce cell motility,
whereas the suppression of Rac1 by syndecan-1 triggered the for-
mation of lamellipodia and the directed migration of cells [27]. In
A431 human squamous carcinoma cells plated on laminin 332,
syndecan-1 formed a complex with a6b4 integrin, which activated
PI3K-Akt-mediated signaling and protected the cells against apop-
tosis [28]. As syndecan family members share several signalingmolecules, there might be functional redundancy and/or a syner-
gistic effect of syndecans and integrins on cell adhesion and migra-
tion. However, it is also possible that the various syndecans might
play unique roles in speciﬁc environment. Therefore, future studies
will be warranted to investigate which syndecans are primarily
responsible for responding to diverse changes in the cellular envi-
ronment, and which signaling networks are involved in the syner-
gistic signaling of syndecans and integrins during cell adhesion.
3. Syndecan as a docking receptor
Another way for the syndecans to mediate the information ﬂow
between the cell and its environment is through their activities as
docking receptors [29–31], which allows them to regulate extracel-
lular events rather than transduce the signals to the interior of the
cell. The heparan sulfate (HS) chains of syndecans play a critical role
in this function [32,33], as they are responsible for recruiting solu-
ble growth factors, such as ﬁbroblast growth factor (FGF), vascular
endothelial growth factor (VEGF), epidermal growth factor (EGF),
hepatocyte growth factor (HGF), platelet derived growth factor
(PDGF), and transforming growth factor b1 (TGFb1) to the mem-
brane, and subsequently allowing them to bind to their receptors
[34–39]. FGF-2 has been thoroughly investigated in this context,
and is a goodmodel for the docking-receptor function of syndecans.
David and co-workers reported that syndecan-1, -2, and -4 sup-
ported the interaction of FGF-2 with FGF receptor (FGFR), and also
increased FGFR1 activation [40]. The binding of FGF-2 to syndecan
achieves high local concentration of FGF-2 at the cell surface. How-
ever, this interaction does not transduce an intracellular signal, but
rather helps FGF-2 bind to FGFR with higher afﬁnity than FGF-2 in
itself, which then transduces the signal [41]. A similar relationship
has been identiﬁed between VEGF and syndecan-2, in that VEGF165
can bind syndecan through a heparin-binding site [42], which then
enhances the binding of VEGF165 to VEGF receptor-2 (VEFGR2) and
activates VEGFR2 [42]. Syndecan-2, which is known to be required
for sprouting angiogenesis in zebraﬁsh development, is believed to
mediate the interaction between VEGF and VEGF receptor [21].
Syndecan-1 has been reported to mediate HGF- and EGF-related
signaling in multiple myeloma [43–47], and HGF and EGF family
members were shown to associate with syndecan-1 for promotion
of cell survival and proliferation [43,46]. The interaction of syndec-
an-1 with HGF has been shown to trigger clustering and activation
of HGF receptor/MET, and the interaction of syndecan-1 with EGF is
known to activate EGF receptor in a similar manner [43,46].
In addition to interacting with growth factors, the HS chains of
syndecans mediate recruitment of various cytokines and chemo-
kines at the cell surface. Syndecans 1, 2, and 3 interact with inter-
leukin-8 (IL-8) on the surface of endothelial cells [48–50]. As an
inﬂammatory response is mounted, interaction of syndecan with
IL-8 generates an IL-8 gradient at the HUVEC cell surface; this
mediates neutrophil recruitment to the site of inﬂammation [48].
In addition, interactions of syndecan HS chains with IL-8 protect
IL-8 from proteolytic degradation [51]. IL-8 stability is thus
maintained and the IL-8-mediated cell response sustained. Granu-
locyte–macrophage colony-stimulating factor (GM-CSF), a hepa-
rin-binding cytokine, binds to syndecan-2 on the surface of
osteoblastic cells; syndecan-2 mediates functional interaction be-
tween GM-CSF and the GM-CSF receptor [52]. In addition, syndecan
may interact with other cytokines and chemokines that bind HS
chains. These interactions may contribute to establishment of che-
mokine/cytokine concentration gradients on cell surfaces, raising
the binding afﬁnities of such materials to their cognate receptors.
In summary, studies to date have revealed that various growth fac-
tors and cytokines may bind to the HS chains of syndecans, thereby
enhancing local concentrations of the former materials and/or the
binding thereof to receptors.
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be recruited to the cell membrane by syndecans [53]. Yu and
Woessner [54] showed that heparan sulfate proteoglycans (HSPGs)
might provide anchoring sites for MMP-7, while other studies have
showed binding between HSPGs and MMP-2, -9, and -13 [55–58].
Berton and co-workers reported that modulation of HSPG levels
decreased the membrane-binding and enzymatic activities of
MMP-7 [59], while other groups showed that MMP-7 can trigger
the shedding of syndecan-1 ectodomains in vivo from the surface
of activated airway epithelia in mice [60,61]. Thus, it is possible
that syndecan-1 docks MMP-7 to the cell surface via its HS chains
and thus exposes itself to MMP-7 as a substrate. Syndecan-2 has
been shown to trigger the processing of pro-MMP-7 into active
MMP-7 [31], suggesting that some syndecans may tether speciﬁc
MMPs and accelerate their activation. In contrast, however, synd-
ecan-2 was found to suppress MMP-2 activation and decrease
metastasis in a Lewis lung carcinoma cell line, whereas a mutated
syndecan-2 lacking the GAG sites did not [56]. This indicates that
the HS chains of syndecan-2 recruit MMP-2 and inhibit activation
thereof. Thus, syndecan may tether extracellular proteases at the
cell surface, either positively or negatively regulating the activities
of these enzymes. It is not yet clear how the syndecans facilitate
the interaction of growth factors with their receptors or seize
and act upon other molecules near the cell surface, but these ef-
fects may involve the establishment of a concentration gradient,
protection from inhibitory or proteolytic molecules, or the forma-
tion of appropriate orientations. In the future, it will be critical
for us to better understand the binding mechanisms of syndecans
with other extracellular ligands.
4. Conclusions
The communication between a cell and its environment is very
important, since cells must respond to change or alter their sur-
roundings in order to adapt and survive. Syndecans are among
the receptor proteins responsible for mediating such signaling,
and are unusual in that they play diverse roles. As summarized
in our prior review [5], their functional diversity might arise at
least in part from their structural diversity. However, syndecans
may also utilize different regulatory mechanisms to perform their
diverse functions.
In order to respond to external stress, a cell must properly mod-
ulate both its internal and external environment. Thus, it would be
useful for a single cell surface receptor to efﬁciently perform both
of these functions. In this review, we propose that syndecans play
dual roles as cell adhesion receptors and docking receptors,
enhancing their ability to recognize and efﬁciently respond to
external stimuli. As cell adhesion receptors, syndecans transduce
‘outside-in’ signals, taking information from the cell exterior and
using it to regulate intracellular events. As docking receptors, syn-
decans regulate proper external cellular responses to the environ-
ment. The ligand speciﬁcities of these roles are not yet clear, but it
seems likely that syndecans use these two different mechanisms to
govern adequate cellular responses. Future studies may reveal how
syndecans select their ligands and the signal direction under vari-
ous conditions.
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